Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Optimizerx Corp (OPRX)

Optimizerx Corp (OPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 142,506
  • Shares Outstanding, K 18,270
  • Annual Sales, $ 71,520 K
  • Annual Income, $ -17,570 K
  • 60-Month Beta 1.27
  • Price/Sales 1.98
  • Price/Cash Flow N/A
  • Price/Book 1.18
Trade OPRX with:

Options Overview Details

View History
  • Implied Volatility 50.61% ( -34.78%)
  • Historical Volatility 51.80%
  • IV Percentile 20%
  • IV Rank 15.62%
  • IV High 179.40% on 03/15/24
  • IV Low 26.77% on 12/01/23
  • Put/Call Vol Ratio 0.00
  • Today's Volume 8
  • Volume Avg (30-Day) 115
  • Put/Call OI Ratio 0.13
  • Today's Open Interest 2,775
  • Open Int (30-Day) 2,565

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate -0.12
  • Number of Estimates 4
  • High Estimate -0.10
  • Low Estimate -0.13
  • Prior Year -0.10
  • Growth Rate Est. (year over year) -20.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.17 +9.34%
on 09/10/24
8.78 -10.71%
on 08/23/24
-0.50 (-6.00%)
since 08/16/24
3-Month
7.17 +9.34%
on 09/10/24
11.53 -32.00%
on 07/30/24
-2.98 (-27.54%)
since 06/18/24
52-Week
6.92 +13.29%
on 10/09/23
16.65 -52.90%
on 03/08/24
-0.18 (-2.24%)
since 09/18/23

Most Recent Stories

More News
OptimizeRx Corporation (OPRX) Q2 2022 Earnings Call Transcript

OPRX earnings call for the period ending June 30, 2022.

OPRX : 7.68 (-1.54%)
UPDATE – OptimizeRx Reports Second Quarter 2022 Financial Results, Innovative Platform Expansions Now Extends Reach to HCPs Across Social Media and Patients at Point-of-Dispense

Revenue Up 3% to $14.0 million, driven by new customer and program launchesIncrease in breadth and scope of brand deal size represents further momentum in...

OPRX : 7.68 (-1.54%)
OptimizeRx Reports Second Quarter 2022 Financial Results, Innovative Platform Expansions Now Extends Reach to HCPs Across Social Media and Patients at Point-of-Dispense

Revenue Up 3% to $14.0 million, driven by new customer and program launchesIncrease in breadth and scope of brand deal size represents further momentum in...

OPRX : 7.68 (-1.54%)
OptimizeRx Sets Second Quarter Fiscal 2022 Conference Call for Tuesday, August 9 at 4:30 p.m. ET

ROCHESTER, Mich., July 21, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology...

OPRX : 7.68 (-1.54%)
OptimizeRx Brings Real-World Evidence-Driven Engagement Programs to Social Media With New Exclusive Partnership

The latest omni-channel platform extension gives pharma access to up to 84% of prioritized HCPs on social media with content that is specific to their...

OPRX : 7.68 (-1.54%)
OptimizeRx’s Mike Rousselle Named One of 2022 PM360 ELITE 100

ROCHESTER, Mich., May 17, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology...

OPRX : 7.68 (-1.54%)
OptimizeRx Authorizes $20 Million Share Repurchase Program

ROCHESTER, Mich., May 17, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology...

OPRX : 7.68 (-1.54%)
OptimizeRx to Participate in Upcoming May Conferences

ROCHESTER, Mich., May 10, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology...

OPRX : 7.68 (-1.54%)
3 Small-Caps That Might Be Acquisition Candidates

Here's why our roundtable thinks OptimizeRx, Affimed and Blueprint Medicines are all buys right now.

OPRX : 7.68 (-1.54%)
AFMD : 4.03 (-0.98%)
BPMC : 89.28 (+3.20%)
TDOC : 9.11 (+0.44%)
DOCS : 40.17 (+0.02%)
OptimizeRx Reports First Quarter 2022 Financial Results, Revenue Up 22%, Successfully Completes EvinceMed Acquisition

Revenue Up 22% to $13.7 million on increased average revenue per top 20 pharmaceutical manufacturer clientTraction with top 20 pharmaceutical manufacturers...

OPRX : 7.68 (-1.54%)

Business Summary

OptimizeRx Corporation provides consumer and physician platforms to help patients better afford and comply with their medicines and healthcare products. It offers pharmaceutical and healthcare companies effective ways to expand patient awareness, access and adherence to their brands. The Company offers...

See More

Key Turning Points

3rd Resistance Point 8.19
2nd Resistance Point 8.10
1st Resistance Point 7.95
Last Price 7.68
1st Support Level 7.71
2nd Support Level 7.62
3rd Support Level 7.47

See More

52-Week High 16.65
Fibonacci 61.8% 12.93
Fibonacci 50% 11.78
Fibonacci 38.2% 10.63
Last Price 7.68
52-Week Low 6.92

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar